Loading…
Zoetis Inc. is projected to rise to $95.84 by 2027, a +24% move from its current price of $77.51. ZTS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/29/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 31 | $76.44 | $77.55 | $78.68 | +0.05% |
| Aug 1 | $76.02 | $77.59 | $79.19 | +0.10% |
| Aug 2 | $75.71 | $77.63 | $79.59 | +0.15% |
| Aug 3 | $75.46 | $77.67 | $79.94 | +0.20% |
| Aug 4 | $75.24 | $77.71 | $80.25 | +0.25% |
| Aug 5 | $75.05 | $77.75 | $80.54 | +0.30% |
| Aug 6 | $74.87 | $77.78 | $80.81 | +0.35% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $74.87 | $77.78 | $80.81 | +0.35% |
| Week 2 | $73.96 | $78.06 | $82.39 | +0.71% |
| Week 3 | $73.32 | $78.34 | $83.69 | +1.07% |
| Week 4 | $72.83 | $78.61 | $84.85 | +1.42% |
| Week 5 | $72.44 | $78.89 | $85.92 | +1.78% |
| Week 6 | $72.10 | $79.17 | $86.93 | +2.14% |
| Week 7 | $71.82 | $79.45 | $87.90 | +2.50% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Zoetis Inc. is a healthcare company focused on animal health. It engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally.
Its products span companion animals such as dogs, cats, and horses, and livestock species including cattle, swine, poultry, fish, and sheep. It also offers parasiticides, dermatology, anti-infectives, pain and sedation, other pharmaceutical products, and animal health diagnostics.
The company markets its products to veterinarians, livestock producers, and pet owners. Zoetis Inc. was incorporated in 2012 and is headquartered in Parsippany, New Jersey.
Zoetis Inc. (ZTS) trades at $76.91 per share and has a market cap of $32.24B. It is ranked 425 in market capitalization and is categorized within the Healthcare sector.
The near-term price outlook for 2026 shows an average price of $76.91 with a range from $71.86 to $105.15 and a 0% ROI, with a NEUTRAL sentiment.
Beyond 2026, the forecast escalates with bullish momentum: 2030 shows an average price of $109.31 (min $85.40, max $148.97) and a 42.1% ROI; 2040 shows an average price of $222.24 (min $157.84, max $338.95) and a 189% ROI; 2050 shows an average price of $381.98 (min $252.95, max $624.52) and a 396.7% ROI.
A major floor 12.1% below — a decisive break under it would weaken the trend.
The nearest floor, 7.3% below — buyers have tended to step in here.
The nearest ceiling, 3.1% above — a clean break opens room to run.
A major ceiling 58.3% above — clearing it would confirm fresh momentum.
Key ZTS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of ZTS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $75.28 | Buy | $75.72 | Buy |
| MA 10 | $75.46 | Buy | $75.56 | Buy |
| MA 20 | $74.99 | Buy | $75.88 | Buy |
| MA 50 | $77.14 | Buy | $81.13 | Sell |
| MA 100 | $95.56 | Sell | $92.10 | Sell |
| MA 200 | $111.77 | Sell | $108.21 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 51.06 | Neutral |
| Stoch RSI (14) | 100.00 | Sell |
| CCI (20) | 125.73 | Buy |
| Williams %R (14) | 0.00 | Info |
| MACD (12,26,9) | 0.47 | Buy |
| ROC (12) | 2.45 | Buy |
| Bollinger %B (20,2) | 0.86 | Neutral |
| Stochastic %K (14) | 100.00 | Sell |
| TRIX (15) | -0.23 | Sell |
| Awesome (5,34) | -1.29 | Sell |
| Ultimate (7,14,28) | 50.15 | Neutral |
| Momentum (10) | 1.53 | Buy |
| Aroon Osc (25) | -28.00 | Sell |
| Hull MA (9) | 75.12 | Buy |
| ADX (14) | 18.44 | Neutral |
| ATR (14) | 1.06 | Info |
The 30-day picture is neutral, with RSI14 at 50 indicating balanced momentum.
The SMA50 is $78.99 and the SMA200 is $114.21, placing the stock near short-term resistance and well below longer-term valuation baselines. The current price of $76.91 sits just above the support level at $71.86 and below the resistance at $82.20.
The 30-day range runs from $69.11 to $85.60, showing a sideways to modestly range-bound movement in the near term.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $71.86 | $77.51 | $105.21 | 0% | Neutral | |
| $78.58 | $95.84 | $122.17 | +24% | Bullish | |
| $82.64 | $102.71 | $134.52 | +33% | Bullish | |
| $87.98 | $111.05 | $148.56 | +43% | Bullish | |
| $86.21 | $110.29 | $150.22 | +42% | Bullish | |
| $89.92 | $116.45 | $161.14 | +50% | Bullish | |
| $94.33 | $123.55 | $173.40 | +59% | Bullish | |
| $101.57 | $134.44 | $191.14 | +73% | Bullish | |
| $118.37 | $158.25 | $227.68 | +104% | Bullish | |
| $122.98 | $165.96 | $241.44 | +114% | Bullish | |
| $156.57 | $220.40 | $336.05 | +184% | Bullish | |
| $254.42 | $384.11 | $627.87 | +396% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $71.86 | $77.51 | $90.68 | +0.00% |
| August 2026 | $68.58 | $80.01 | $95.14 | +3.22% |
| September 2026 | $69.19 | $81.16 | $97.40 | +1.45% |
| October 2026 | $68.60 | $80.84 | $97.73 | -0.40% |
| November 2026 | $70.08 | $82.90 | $100.81 | +2.54% |
| December 2026 | $72.50 | $86.04 | $105.21 | +3.80% |
Click any year to see its month-by-month ZTS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
The ZTS price prediction for 2026 points to an average of $77.51 (low $71.86, high $105.21) — a potential gain of 0% on today's $77.51. Price action looks broadly range-bound.
In 2027, ZTS is projected to trade between $78.58 and $122.17, averaging $95.84 — a potential gain of +24% from today's $77.51. That is up +24% on the projected 2026 average. Buyers look set to stay in control over this stretch.
Zoetis Inc.'s 2028 outlook centres on $102.71, within a $82.64 to $134.52 range. That is up +7% on the projected 2027 average. That marks a +33% change versus current levels. Momentum favours further upside here.
By 2029, ZTS could reach as high as $148.56, with a base case around $111.05 and support toward $87.98 — roughly +43% from $77.51. Buyers look set to stay in control over this stretch.
Expect ZTS to range from $86.21 to $150.22 through 2030. The $110.29 average target implies a +42% move from current prices. That is -1% versus the projected 2029 average. Momentum favours further upside here.
The ZTS price prediction for 2031 points to an average of $116.45 (low $89.92, high $161.14) — a potential gain of +50% on today's $77.51. Buyers look set to stay in control over this stretch.
In 2032, ZTS is projected to trade between $94.33 and $173.40, averaging $123.55 — a potential gain of +59% from today's $77.51. That is up +6% on the projected 2031 average. Momentum favours further upside here.
Zoetis Inc.'s 2033 outlook centres on $134.44, within a $101.57 to $191.14 range. That is up +9% on the projected 2032 average. That marks a +73% change versus current levels. Buyers look set to stay in control over this stretch.
By 2034, ZTS could reach as high as $227.68, with a base case around $158.25 and support toward $118.37 — roughly +104% from $77.51. Momentum favours further upside here.
Expect ZTS to range from $122.98 to $241.44 through 2035. The $165.96 average target implies a +114% move from current prices. That is up +5% on the projected 2034 average. Buyers look set to stay in control over this stretch.
The ZTS price prediction for 2040 points to an average of $220.40 (low $156.57, high $336.05) — a potential gain of +184% on today's $77.51. Momentum favours further upside here.
In 2050, ZTS is projected to trade between $254.42 and $627.87, averaging $384.11 — a potential gain of +396% from today's $77.51. That is up +74% on the projected 2040 average. Buyers look set to stay in control over this stretch.
Investing $1,000 in ZTS today (≈ 12.901561 ZTS) could be worth
$4,955.61
+$3,955.61 (+396%) by 2050 · US Dollar
Based on the average projected ZTS price of $384.11 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in ZTSwould be worth at today's price.
$1,000 invested in ZTS on Jul 28, 2025 (≈ 6.633499 ZTS) would be worth
$514.16
-$485.84 (-48.6%) today · 0.51× · US Dollar
Based on a ZTS entry price of $150.75 vs. today's $77.51.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $76.2 | $1,017.19 | +1.7% |
| 1 month ago | $76.09 | $1,018.66 | +1.9% |
| 3 months ago | $116.65 | $664.47 | -33.6% |
| 6 months ago | $121.93 | $635.69 | -36.4% |
| 1 year ago | $150.75 | $514.16 | -48.6% |
| All time (5.0y) ago | $202.11 | $383.5 | -61.6% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our ZTS forecast.
Our base-case forecast reaches $160.00 around 2035.
Implied market cap at $160.00: $67.08B
The multi-year forecast paints a bullish path for Zoetis, with rising averages and sizable ROI in the outer years. By 2030 the average price is forecast at $109.31 with a 42.1% ROI, supported by a min of $85.40 and a max of $148.97.
Looking further to 2040, the average is projected to $222.24 with a 189% ROI, and a range from $157.84 to $338.95—indicating substantial upside potential.
By 2050, the average is forecast at $381.98 with a 396.7% ROI, spanning a min of $252.95 and a max of $624.52. These figures imply a strong long-term uptrend, though they are estimates and subject to uncertainty and market dynamics.
Tap a question to reveal the answer.
2030 avg $109.31; min $85.40; max $148.97; ROI 42.1%; sentiment BULLISH.
Short-term 2026 shows neutral sentiment with avg $76.91 and ROI 0%. Longer-term outlook remains BULLISH with rising averages and ROIs through 2050.
Yes. The 2040 forecast shows avg $222.24, min $157.84, max $338.95, ROI 189%, indicating the potential to exceed $200.
Current price is $76.91 and market cap is $32.24B.
RSI14 is 50 (neutral). SMA50 is $78.99 and SMA200 is $114.21. The 30-day range is $69.11 to $85.60. Support sits at $71.86 and resistance at $82.20.
Zoetis Inc. Community Discussion
0Share your Zoetis Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.